Efficacy and safety of tretinoin 0.025%/clindamycin phosphate 1.2% gel in combination with benzoyl peroxide 6% cleansing cloths for the treatment of facial acne vulgaris

Journal of Drugs in Dermatology

Volumn 12, Issue 3, 2013, Pages 277-282

  Zeichner, Joshua A ^a   Haddican, Madelaine ^a   Linkner, Rita V ^a   Wong, Vicky ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE PLUS RETINOIC ACID;

ACNE VULGARIS; ADOLESCENT; ADULT; ARTICLE; BRONCHITIS; BURNING SENSATION; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLOTHING; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRY SKIN; ERYTHEMA; FACE; FEMALE; FOAMING; FOAMING CLOTH; GEL; HUMAN; HYPERTENSION; MALE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SKIN IRRITATION; STINGING; TREATMENT DURATION; TREATMENT OUTCOME;

ACNE VULGARIS; ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; BENZOYL PEROXIDE; CLINDAMYCIN; DERMATOLOGIC AGENTS; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FACE; FEMALE; GELS; HUMANS; MALE; MIDDLE AGED; SINGLE-BLIND METHOD; TRETINOIN; YOUNG ADULT;

EID: 84874632313     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Thiboutot D, Gollnick H, Bettoli V, et al Global Alliance to Improve Outcomes in Acne. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol. 2009;60(5 Suppl):S1-S50.
2. Leyden JJ. A review of the use of combination therapies for the treatment of acne vulgaris. J Am Acad Dermatol. 2003;49(3 Suppl):S200-S210. (Pubitemid 37046534)
3. Thielitz A, Sidou F, Gollnick H. Control of microcomedone formation throughout a maintenance treatment with adapalene gel, 0.1%. J Eur Acad Dermatol Venereol. 2007;21(6):747-753. (Pubitemid 46939044)
4. Liu PT, Krutzik SR, Kim J, Modlin RL. Cutting edge: all-trans retinoic acid downregulates TLR2 expression and function. J Immunol. 2005;174(5):2467- 2470. (Pubitemid 40279655)
5. Tanghetti EA, Popp KF. A current review of topical benzoyl peroxide: new perspectives on formulation and utilization. Dermatol Clin. 2009;27(1):17-24.
6. Yentzer BA, Ade RA, Fountain JM, et al. Simplifying regimens promotes greater adherence and outcomes with topical acne medications: a randomized controlled trial. Cutis. 2010;86(2):103-108.
7. Millikan LE. The rationale for using a topical retinoid for inflammatory acne. Am J Clin Dermatol. 2003;4(2):75-80. (Pubitemid 36259516)
8. Gollnick H, Cunliffe W, Berson D, et al Global Alliance to Improve Outcomes in Acne. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49(1 Suppl):S1-S37. (Pubitemid 36791495)
9. Eady EA, Bojar RA, Jones CE, Cover JH, Holland KT, Cunliffe WJ. The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin?resistant propionibacteria. Br J Dermatol. 1996;134(1):107-113. (Pubitemid 26030998)
10. Cunliffe WJ, Holland KT, Bojar R, Levy SF. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris. Clin Ther. 2002;24(7):1117-1133. (Pubitemid 34833234)
11. Gold LS. Fixed-combination products in the management of acne vulgaris. Cutis. 2010;85(3):160-167.
12. Taylor GA, Shalita AR. Benzoyl peroxide-based combination therapies for acne vulgaris: a comparative review. Am J Clin Dermatol. 2004;5(4):261-265 (Pubitemid 39127968)
13. Mills OH Jr, Kligman AM, Pochi P, Comite H. Comparing 2.5%, 5%, and 10% benzoyl peroxide on inflammatory acne vulgaris. Int J Dermatol. 1986;25(10):664-667. (Pubitemid 17210594)
14. Ockenfels HM, Uter W, Lessmann H, Schnuch A, Geier J. Patch testing with benzoyl peroxide: reaction profile and interpretation of positive patch test reactions. Contact Dermatitis. 2009;61(4):209-216.
15. Berson DS, Chalker DK, Harper JC, Leyden JJ, Shalita AR, Webster GF. Current concepts in the treatment of acne: report from a clinical roundtable. Cutis. 2003;72 (1 Suppl):5-13.
16. Leyden JJ, Grossman R, Nighland M. Cumulative irritation potential of topical retinoid formulations. J Drugs Dermatol. 2008;7(8 Suppl):s14-s18.
17. Leyden JJ, Wortzman M, Baldwin EK. Antibiotic-resistant Propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%. Cutis. 2008;82(6):417-421.
18. Del Rosso JQ. Benzoyl peroxide cleansers for the treatment of acne vulgaris: status report on available data. Cutis. 2008;82(5):336-342.
19. Thielitz A, Gollnick H. Topical retinoids in acne vulgaris: update on efficacy and safety. Am J Clin Dermatol. 2008;9(6):369-381.
20. Dosik JS, Vamvakias G. Comparative irritation potential of two combination acne products: a randomized controlled, subject- and evaluator-blind, comparative study in healthy volunteers. Am J Clin Dermatol. 2008;9(5):313-317.
21. Del Rosso JQ. A 6% benzoyl peroxide foaming cloth cleanser used in the treatment of acne vulgaris: aesthetic characteristics, patient preference considerations, and impact on compliance with treatment. J Clin Aesthet Dermatol. 2009;2(7):26-29.
22. Draelos ZD, Ertel KD, Berge CA. Facilitating facial retinization through barrier improvement. Cutis. 2006;78(4):275-281. (Pubitemid 44720416)
23. Kircik LH. Comparative efficacy and safety results of two topical combination acne regimens. J Drugs Dermatol. 2009;8(7):624-630.
24. Del Rosso JQ, Kircik L. Comparison of the tolerability of benzoyl peroxide microsphere wash vs a gentle cleanser, when used in combination with a clindamycin and tretinoin gel: A multicenter, investigator-blind, randomized study [abstract]. J Am Acad Dermatol. 2009;60(3 Suppl 1):AB17.
25. Draelos ZD, Potts A, Alió Saenz AB; W0265-306 Study Group. Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris. Cutis. 2010;86(6):310-318.
26. Pariser DM, Westmoreland P, Morris A, Gold MH, Liu Y, Graeber M. Longterm safety and efficacy of a unique fixed-dose combination gel of adapalene 0.1% and benzoyl peroxide 2.5% for the treatment of acne vulgaris. J Drugs Dermatol. 2007;6(9):899-905.
27. Schlessinger J, Menter A, Gold M, et al ZIANA Study Group. Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris. J Drugs Dermatol. 2007;6(6):607-615.
28. Lott R, Taylor SL, O'Neill JL, Krowchuk DP, Feldman SR. Medication adherence among acne patients: a review. J Cosmet Dermatol. 2010;9(2):160-166.
29. Carroll CL, Feldman SR, Camacho FT, Manuel JC, Balkrishnan R. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol. 2004;51(2):212-216.
30. Gadkari AS, McHorney CA. Unintentional non-adherence to chronic prescription medications: How unintentional is it really? BMC Health Serv Res. 2012 Jun 14;12:98.
31. Giacomoni PU, Mammone T, Teri M. Gender-linked differences in human skin. J Dermatol Sci. 2009;55(3):144-149.
32. Jacobi U, Gautier J, Sterry W, Ladermann J. Gender-related differences in the physiology of the stratum corneum. Dermatology. 2005;211(4):312-317. (Pubitemid 41642103)
33. Shuster S, Black MM, McVitie E. The influence of age and sex on skin thickness, skin collagen and density. Br J Dermatol. 1975;93(6):639-643.
34. Eady EA, Cove JH, Blake J, Holland KT, Cunliffe WJ. Recalcitrant acne vulgaris. Clinical, biochemical and microbiological investigation of patients not responding to antibiotic treatment. Br J Dermatol. 1988;118(3):415-423.